1. Research and Innovation Golden Jubilee Foundation

2. Angela Harkness Director of Global Development and Strategic Partnerships
Dr Catherine Sinclair Research Manager

3. NHS Golden Jubilee Foundation
Golden Jubilee National Hospital
Golden Jubilee Research Institute
Golden Jubilee Conference Hotel
Golden Jubilee Innovation Centre 3

5. Scotland’s 2020 vision for Health
“To increase investment in innovation
which drives quality of care
reduce cost
provide growth in the economy”
Scottish Government

6. Golden Jubilee’s Vision
Leading Quality, Research and Innovation

7. GJF’s Quality Framework
Mortality
Complaints
Compassion & Caring
Incidents & Risk
Infection Control
Nutrition, Falls, Dementia
Satisfaction & Values
Involvement in Care
Cancellations
Values
Quality Performance
Medical Appraisal
Surveys/opinions
% Sickness
Turnover
Leadership
Prescribing
Financial
Capital
Wait Times
Productivity
Diagnostics (Ca)
Hotel Occupancy
Expansion Plans

8. GJF’s Quality Framework

9. GJF’s Quality Framework

10. Innovation through research
The Medical Device alpha Test (MDαT®)

11. Why MDαT®? 25% research portfolio - device projects
Expertise of device related research projects
Gap in the market
Targeted towards SME’s

12. MDαT® - our principles Inspired by ‘ideas factory’ concept
Panel review of device
Expert advisors
Non-Disclosure Agreement signed
IP belongs to the presenting organisation
Outcome reported
Continued partnership
Introduction though SLA, HIP , word on moth etc
Triage – CS, RH and exec team

13. Case study - Braidlock
Introduction - Scottish Lifesciences Association
Device - Affixes lines such as IV sets, infusion pumps, Robinson drains, etc.
MDαT® event held
Outcome
Evaluation at the Golden Jubilee

14. Case study - Synchrophi
Introduction - Scottish Lifesciences Association
Device - KEWS300, a CE-marked software suite - captures, stores and presents patient vital signs; calculates MEWS scores
MDαT® event held
Outcome
Evaluation – Ward 3 West (cardiothoracic surgery)
Partnership and roll out to all wards
Option -‘Once for Scotland’
The Modified Early Warning Score (MEWS) is a simple, physiological score that may allow improvement in the quality and safety of management provided to surgical ward patients. The primary purpose is to prevent delay in intervention or transfer of critically ill patients
Partnership – visit to hospitals in Galway where device was in use; further development of system to integrate with patient care e-systems; training staff of evaluation ward
Evaluation – Real time patient observations; improvement in calculation of EWS – 100% error free; accurate time for repeat observations
Ongoing – GJ is a reference site for the device; roll-out on a cost only basis

15. MDαT® – what next? Golden Jubilee coordinated
Share as a Once for Scotland
Create a Scotland wide panel review of Medical Devices

16. Scotland’s passion
for innovation

17. The future - MDαT®

18. Building Collaboration
Route to market
Product enhancement - guidance
Support delivery
Strategic Partnerships
Income generation via % return on sales
Developing a ‘Once for Scotland’ approach

19. Building on experience
Robust Management and Governance
Custodians of SBRI Investment
Supporting DHI’s Strategic Partnerships - AF Project
Existing commercial relationships - SME’s National and International Links
Supporting Economic Growth and Investment
Securing return on investment

20. The Innovation Fund Commercial Partnerships Public Facing Fundraising
Match Innovation with Sponsorship/Investments
Public Facing Fundraising
V Code Innovation, Free Wills etc, Public Fundraising Events
Charitable Organisations
Promoting Charitable Status. Identifying Projects for Funding
European & Worldwide
Quality Framework, EPR, ERAS, Gold Care, Research Opportunities
Promoting Scotland’s Healthcare worldwide – promote quality, explore consultancy and generate income
Alumni & Philanthropic
Identify Ambassadors to help link Innovation and Major Donors (e.g. Golden Jubilee Lectures)